Literature DB >> 12569282

Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: fine mapping in search of a possible tumour suppressor gene region.

Micaela Poetsch1, Thomas Dittberner, Christian Woenckhaus.   

Abstract

Deletions in 1p36 in malignant melanoma have been found in high percentages in nodular melanomas and melanoma metastases. Despite many efforts, no candidate tumour suppressor gene associated with malignant melanoma has so far been found in this region. To further determine a possible tumour suppressor gene locus, we carried out a deletion mapping of chromosome 1p36 at nine microsatellite loci in 74 malignant melanomas. Loss of heterozygosity (LOH) in this region was found in 77% of nodular melanomas (NMs), 86% of metastatic melanomas, but only 20% of superficial spreading melanomas (SSMs). Regarding the allelic losses, the nodular and metastatic melanoma samples could be divided into three groups: one showing LOH at the more telomeric loci D1S243 and D1S468 (1p36.33), one displaying allelic loss at the more centromeric loci D1S214 and D1S253 (1p36.32-31) and one with LOH over all informative loci between D1S243 and D1S160. We did not find any significant correlation between a deletion in any of the investigated loci and the survival data of the patients. However, our results confine the deleted region in malignant melanoma to a very small area around 1p36.32, thus facilitating the search for the tumour suppressor gene with importance in malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12569282     DOI: 10.1097/00008390-200302000-00006

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  14 in total

Review 1.  Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.

Authors:  Alea A Mills
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

2.  1p36.32 rearrangements and the role of PI-PLC η2 in nervous tumours.

Authors:  Vincenza Rita Lo Vasco
Journal:  J Neurooncol       Date:  2010-09-29       Impact factor: 4.130

3.  The tumor suppressor Chd5 is induced during neuronal differentiation in the developing mouse brain.

Authors:  Assaf Vestin; Alea A Mills
Journal:  Gene Expr Patterns       Date:  2013-10-09       Impact factor: 1.224

4.  Genetic markers of oral malignant melanoma analysed by fluorescence in situ hybridisation (FISH).

Authors:  Chiara Baldovini; Anna L Tosi; Enrico Di Oto; Camilla Reggiani; Susanna Cappia; Christine M Betts; Carmine Gallo; Lisa Ricchieri; Roberto Cocchi; Maria P Foschini
Journal:  Virchows Arch       Date:  2011-06-29       Impact factor: 4.064

5.  Analysis of the miR-34a locus in 62 patients with familial cutaneous melanoma negative for CDKN2A/CDK4 screening.

Authors:  Angela M Cozzolino; Lucia Pedace; Marco Castori; Paola De Simone; Nicoletta Preziosi; Isabella Sperduti; Chiara Panetta; Valerio Mogini; Carmelilia De Bernardo; Aldo Morrone; Caterina Catricalà; Paola Grammatico
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

6.  Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma.

Authors:  Robert J Clifford; Jinghui Zhang; Daoud M Meerzaman; Myung-Soo Lyu; Ying Hu; Constance M Cultraro; Richard P Finney; Jenny M Kelley; Sol Efroni; Sharon I Greenblum; Cu V Nguyen; William L Rowe; Sweta Sharma; Gang Wu; Chunhua Yan; Hongen Zhang; Young-Hwa Chung; Jeong A Kim; Neung Hwa Park; Il Han Song; Kenneth H Buetow
Journal:  Hepatology       Date:  2010-12       Impact factor: 17.425

7.  Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cells.

Authors:  Jan-Paul Flacke; Hanna Flacke; Avinash Appukuttan; Rein-Jüri Palisaar; Joachim Noldus; Brian D Robinson; H Peter Reusch; Jonathan H Zippin; Yury Ladilov
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

8.  Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study.

Authors:  Mauro Longoni; Francesca Orzan; Michela Stroppi; Nicola Boari; Pietro Mortini; Paola Riva
Journal:  Neuro Oncol       Date:  2007-12-19       Impact factor: 12.300

Review 9.  The quest for the 1p36 tumor suppressor.

Authors:  Anindya Bagchi; Alea A Mills
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

10.  Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.

Authors:  Minoru Kitago; Steve R Martinez; Takeshi Nakamura; Myung-Shin Sim; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2009-03-31       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.